November 15, 2018Prominent investor Mark Cuban has made a new investment in Perlara, a public benefit company that uses model organsisms, including Drosophila, as part of their efforts to identify new treatments for rare diseases. Read news coverage here.See also: all, biologists (non-fly experts), Drosophila experts, physician-scientists, students, teachers (K-12), the public
